These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Goldkorn A; Blackburn EH Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715 [TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. de Souza Nascimento P; Alves G; Fiedler W Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926 [TBL] [Abstract][Full Text] [Related]
4. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. Kelland LR Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745 [TBL] [Abstract][Full Text] [Related]
5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hayashidani Y; Hiyama E; Murakami Y; Sueda T Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061 [TBL] [Abstract][Full Text] [Related]
7. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA. Kurvinen K; Syrjänen S; Johansson B Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210 [TBL] [Abstract][Full Text] [Related]
8. [The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells]. Zheng SJ; Xia Y; Ren H; Zhong S; Yang Y; Tao P; Wang SQ Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):530-3. PubMed ID: 15387903 [TBL] [Abstract][Full Text] [Related]
9. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line]. Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667 [TBL] [Abstract][Full Text] [Related]
10. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro]. Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference. Miri-Moghaddam E; Deezagi A; Soheili ZS Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors. Chen SM; Tao ZZ; Hua QQ; Xiao BK; Xu Y; Wang Y; Deng YQ Cancer Invest; 2007 Dec; 25(8):691-8. PubMed ID: 18058464 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity. Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810 [TBL] [Abstract][Full Text] [Related]
15. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Kelland L Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545 [TBL] [Abstract][Full Text] [Related]
16. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells. Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
18. Multiple pathways for the regulation of telomerase activity. Holt SE; Wright WE; Shay JW Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells]. Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050 [TBL] [Abstract][Full Text] [Related]
20. Telomerase as a therapeutic target for malignant gliomas. Komata T; Kanzawa T; Kondo Y; Kondo S Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]